Preventive and Therapeutic Effect of Ganoderma (Lingzhi) on Liver Injury

Author(s):  
Zhiwei Qiu ◽  
Dandan Zhong ◽  
Baoxue Yang
2000 ◽  
Vol 28 (02) ◽  
pp. 175-185 ◽  
Author(s):  
Jung-Chou Chen ◽  
Chin-Chuan Tsai ◽  
Leih-Der Chen ◽  
Hing-Ho Chen ◽  
Wen-Chuang Wang

Gypenoside is a saponins extract derived from the Gynostemma pentaphyllum. The purpose of this study was to evaluate the hepatoprotective and antifibrotic potential of Gypenoside on chronic liver injury induced by CCl 4 for 8 wks. The results indicated that the increase of SGOT, SGPT activities in CCl 4 liver injury were significantly reduced by treatment with Gypenoside. It also elevated the A/G ratio. For the study of anti-fibrotic potential, Gypenoside reduced the collagen content by 33%. These phenomena were confirmed by pathologic observation; thinner bands of liver collagen were found. The results suggest that Gypenoside has hepatoprotective and anti-fibrotic activities.


2020 ◽  
Vol 189 (4) ◽  
pp. 1189-1194 ◽  
Author(s):  
Nilgun Eroglu ◽  
Erol Erduran ◽  
Gokce Pinar Reis ◽  
Aysenur Bahadır

2020 ◽  
Vol 29 ◽  
pp. 096368972092999 ◽  
Author(s):  
Guanghui Xiu ◽  
Xiuling Li ◽  
Yunyu Yin ◽  
Jintao Li ◽  
Bingqin Li ◽  
...  

Mesenchymal stem cells (MSCs) are thought to have great potential in the therapy of acute liver injury. It is possible that these cells may be regulated by the stromal cell-derived factor-1 (SDF-1)/CXC chemokine receptor-4 (CXCR4) signaling axis, which has been shown to promote stem cells migration in the inflammation-associated diseases. However, the effects of SDF-1/CXCR4 axis on the MSCs-transplantation-based treatment for acute liver injury and the underlying mechanisms are largely unknown. In this study, we sought to determine whether SDF-1/CXCR4 would augment the therapeutic effect of bone marrow mesenchymal stem cells (BMSCs) by promoting their migration, which may result from activating the phosphoinositide 3-kinase (PI3K)/Akt signaling pathway, in a rat acute liver injury model induced by lipopolysaccharide (LPS). We found that BMSCs transplantation markedly attenuated liver injury and improved the survival of LPS-treated rats. Of interest, overexpression of CXCR4 in BMSCs could substantially promote their migration both in vitro and in vivo, and result in even better therapeutic effects. This might be attributed to the activation of PI3K/Akt signaling pathway in BMSCs that is downstream of CXCR4, as demonstrated by the use of the CXCR4 antagonist AMD3100 and PI3K pathway inhibitor LY294002 assays in vitro and in vivo. Together, our results unraveled a novel molecular mechanism for the therapeutic effect of BMSCs for the treatment of acute liver injury, which may shed a new light on the clinical application of BMSCs for acute liver failure.


1985 ◽  
Vol 85 (4) ◽  
pp. 249-257 ◽  
Author(s):  
Satoshi YUASA ◽  
Atsuko SUDOH ◽  
Kazuo TOSHIDA ◽  
Masato TAKECHI ◽  
Kohei UMEZU

2001 ◽  
Vol 433 (2-3) ◽  
pp. 177-185 ◽  
Author(s):  
Isao Sumioka ◽  
Tatsuya Matsura ◽  
Kazuo Yamada

2000 ◽  
Vol 28 (2) ◽  
pp. 119-126 ◽  
Author(s):  
Yoshiji Ohta ◽  
Mutsumi Kongo ◽  
Emi Sasaki ◽  
Keiji Nishida ◽  
Isao Ishiguro

Sign in / Sign up

Export Citation Format

Share Document